5-hydroxypyrazinoic acid has been researched along with pyrazinamide in 6 studies
| Studies (5-hydroxypyrazinoic acid) | Trials (5-hydroxypyrazinoic acid) | Recent Studies (post-2010) (5-hydroxypyrazinoic acid) | Studies (pyrazinamide) | Trials (pyrazinamide) | Recent Studies (post-2010) (pyrazinamide) |
|---|---|---|---|---|---|
| 7 | 1 | 3 | 3,626 | 320 | 1,113 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (16.67) | 18.7374 |
| 1990's | 3 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Duwoos, H; Lacroix, C; Lafont, O; Phan Hoang, T; Tranvouez, JL | 1 |
| Guyonnaud, C; Lacroix, C; Lafont, O; Laine, G; Menager, S; Poncet, P; Ray, M | 1 |
| Higashino, K; Moriwaki, Y; Suda, M; Takahashi, S; Yamamoto, T | 1 |
| André, D; Chabenat, C; Lafont, O; Mehmedagic, A; Ménager, S; Tharasse, C; Vérité, P | 1 |
| Sanyal, M; Shah, JV; Shah, PA; Sharma, P; Shrivastav, PS | 1 |
| Chaturvedi, S; Dubey, D; Guleria, A; Keshari, AK; Kumar, D; Kumar, U; Prakash, A; Rai, A; Raj, V; Rawat, A; Saha, S; Singh, AK | 1 |
1 trial(s) available for 5-hydroxypyrazinoic acid and pyrazinamide
| Article | Year |
|---|---|
Xylitol-induced increase in the concentration of oxypurines and its mechanism.
Topics: Administration, Oral; Adult; Chromatography, High Pressure Liquid; Cytosol; Humans; Hypoxanthine; Hypoxanthines; Infusions, Intravenous; Inosine; Intestine, Small; Lactates; Lactic Acid; Liver; Male; Middle Aged; NAD; Phosphates; Pyrazinamide; Pyruvates; Pyruvic Acid; Saline Solution, Hypertonic; Serum Albumin; Uric Acid; Xanthine; Xanthine Dehydrogenase; Xanthines; Xylitol | 1995 |
5 other study(ies) available for 5-hydroxypyrazinoic acid and pyrazinamide
| Article | Year |
|---|---|
Pharmacokinetics of pyrazinamide and its metabolites in patients with hepatic cirrhotic insufficiency.
Topics: Adult; Chromatography, High Pressure Liquid; Female; Half-Life; Humans; Liver Cirrhosis; Liver Function Tests; Male; Pyrazinamide | 1990 |
[Microdetermination of pyrazinamide and its metabolites (pyrazinoic acid, 5-hydroxypyrazinoic acid, 5-hydroxypyrazinamide and pyrazinuric acid) in plasma and urine with liquid chromatography].
Topics: Chromatography, High Pressure Liquid; Chromatography, Ion Exchange; Humans; Indicators and Reagents; Pyrazinamide; Spectrometry, Fluorescence; Spectrophotometry, Ultraviolet | 1987 |
Determination of pyrazinamide and its main metabolites in rat urine by high-performance liquid chromatography.
Topics: Animals; Antitubercular Agents; Chromatography, High Pressure Liquid; Female; Gas Chromatography-Mass Spectrometry; Pyrazinamide; Rats; Rats, Sprague-Dawley; Reproducibility of Results | 1997 |
An improved LC-MS/MS method for the simultaneous determination of pyrazinamide, pyrazinoic acid and 5-hydroxy pyrazinoic acid in human plasma for a pharmacokinetic study.
Topics: Calibration; Chromatography, Liquid; Humans; Pyrazinamide; Quality Control; Reference Standards; Tandem Mass Spectrometry | 2016 |
Metabolomics approach discriminates toxicity index of pyrazinamide and its metabolic products, pyrazinoic acid and 5-hydroxy pyrazinoic acid.
Topics: Administration, Oral; Animals; Antitubercular Agents; Biomarkers; Biotransformation; Chemical and Drug Induced Liver Injury; Liver; Male; Metabolomics; Microscopy, Electron, Scanning; Multivariate Analysis; Oxidative Stress; Proton Magnetic Resonance Spectroscopy; Pyrazinamide; Rats, Wistar; Risk Assessment; Time Factors; Toxicity Tests | 2018 |